Soleno Therapeutics, Inc. (SLNO)
46.58
+0.28
(+0.60%)
USD |
NASDAQ |
Jan 02, 12:14
Soleno Therapeutics EPS Diluted (Quarterly): 0.4736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AVITA Medical, Inc. | -0.4644 |
| Agilon Health, Inc. | -0.2659 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Geron Corp. | -0.0276 |
| Cassava Sciences, Inc. | -0.2237 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.01M |
| Revenue (Quarterly) | 66.02M |
| Total Expenses (Quarterly) | 40.00M |
| Enterprise Value | 2.041B |
| Gross Profit Margin (Quarterly) | 98.27% |
| Profit Margin (Quarterly) | 39.40% |
| Earnings Yield | -3.95% |
| Normalized Earnings Yield | -3.797 |